Geneva, Switzerland – January 10th, 2023 – SOPHiA GENETICS™ (Nasdaq: SOPH), a cloud-native...
SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies
read more
Press releases
New Data Presented at ESGO Showcases Clinical Relevance of SOPHiA DDM™ Dx HRD Solution
The CE-IVD certified application further assists in clinical decisions related to advanced ovarian...
SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis
The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data...
SOPHiA GENETICS To Lead Panel on Artificial Intelligence, Multimodal Data, and its Role in Medicine at BioData World Congress on Nov. 9, 2022
BASEL, Switzerland - October 31, 2022 — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software...
SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event
Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and...
SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference
BOSTON and LAUSANNE, Switzerland, Sept. 02, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq:...
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
Steady Operational Performance Amidst Macroeconomic Headwinds BOSTON and LAUSANNE, Switzerland,...
SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City
BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq:...
SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference
BOSTON and LAUSANNE, Switzerland, July 29, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq:...
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022
BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq:...
SOPHiA GENETICS Publishes Environmental, Social and Governance Impact Summary
BOSTON, United States and LAUSANNE, Switzerland, June 15, 2022 — SOPHiA GENETICS SA (Nasdaq: SOPH)...
SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting
BOSTON and LAUSANNE, Switzerland, June 15, 2022 /PRNewswire/ -- SOPHiA...